{"name":"Essentialis, Inc.","slug":"essentialis-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Diazoxide Choline Controlled-Release Tablet","genericName":"Diazoxide Choline Controlled-Release Tablet","slug":"diazoxide-choline-controlled-release-tablet","indication":"Hypertension","status":"phase_2"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"DCCR","genericName":"DCCR","slug":"dccr","indication":"Solid tumors with high CDK8 expression","status":"phase_3"}]}],"pipeline":[{"name":"Diazoxide Choline Controlled-Release Tablet","genericName":"Diazoxide Choline Controlled-Release Tablet","slug":"diazoxide-choline-controlled-release-tablet","phase":"phase_2","mechanism":"Potassium channel blocker","indications":["Hypertension"],"catalyst":""},{"name":"DCCR","genericName":"DCCR","slug":"dccr","phase":"phase_3","mechanism":"DCCR is a small molecule that inhibits the activity of the CDK8 protein.","indications":["Solid tumors with high CDK8 expression"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTFBWUEtzdzlPM1kwM1o1dHZZbjExZkxjN3pHSzcwMmdJX25wekdqdmVSVjFsRzFWaTZ4NkY0WVdRSjZwM3NFTnBSQkxUR1JRb3d6U1piR3BlUklzNEZJcTdtUXJmSGF0WkRvNGc?oc=5","date":"2025-09-02","type":"pipeline","source":"Fierce Pharma","summary":"Soleno Therapeutics - Fierce Pharma","headline":"Soleno Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTFBmeWJ6UjcwemNBUnkyTnh2bEotd1Vtcy1aeEdiMGxOXzYzNXZsMm81YXhyRlJiUHU0SEF6ZTVUS0dNOUlkLTZobVVvZEhNX0dNd0V6N3RuU0dwQXhJWHQxYnpPWkt5cWJOR2pSZG9FbnV5NnRmNFlrTWRxdW8?oc=5","date":"2024-06-04","type":"pipeline","source":"citybiz","summary":"Amarin Appoints Aaron Berg as CEO - citybiz","headline":"Amarin Appoints Aaron Berg as CEO","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":1,"phase_3":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}